Detalles de la búsqueda
1.
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.
J Am Soc Nephrol;
32(8): 2020-2030, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244326
2.
Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.
Nephrol Dial Transplant;
36(9): 1694-1703, 2021 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624825
3.
On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses?
Digestion;
88(1): 56-63, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23880545
4.
Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.
Pain Pract;
13(1): 30-40, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22510252
5.
Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.
PLoS One;
18(5): e0285606, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216375
6.
Sex differences in the generalizability of randomized clinical trials in heart failure with reduced ejection fraction.
Eur J Heart Fail;
25(6): 912-921, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101398
7.
Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD.
Int J Neuropsychopharmacol;
15(1): 1-13, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21798108
8.
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction.
Eur Heart J Qual Care Clin Outcomes;
8(7): 761-769, 2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596659
9.
A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps.
Sci Rep;
11(1): 1784, 2021 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33469061
10.
A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.
Pain Pract;
10(5): 404-15, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20384968
11.
Low hemoglobin at hemodialysis initiation: an international study of anemia management and mortality in the early dialysis period.
Clin Kidney J;
13(3): 425-433, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32699623
12.
Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.
J Clin Psychiatry;
73(8): 1097-102, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22780962
13.
A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate-to-Severe Chronic Pain Induced by Osteoarthritis of the Hip or the Knee.
Pain Res Treat;
2011: 239501, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22110921
Resultados
1 -
13
de 13
1
Próxima >
>>